About Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
Clinical Trials at Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
During the past decade, Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
According to Clinical.Site data, the most researched conditions in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche" are
"Geographic Atrophy" (3 trials), "Branch Retinal Vein Occlusion" (1 trials), "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche" in a lesser frequency.
Clinical Trials Intervention Types at Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
Most popular intervention types in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche" are "Drug" (5 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (3 trials), "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
The vast majority of trials in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche" are
6 trials for "All" genders.
Clinical Trials Status at Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche
Currently, there are NaN active trials in "Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Fondazione Ptv Policlinico Tor Vergata Di Roma;U.O.S.D. Patologie Renitiche, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".